Jeff Yass’s Kindred Biosciences, Inc. KIN Stock Holding History

Jeff Yass’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-34,100	Closed	-$313K	–	14069
2021 Q2	$313K	Sell	34,100 -24,000	-41%	-$140K	﹤0.01%	10697
2021 Q1	$289K	Buy	58,100 +37,800	+186%	+$183K	﹤0.01%	10689
2020 Q4	$87K	Buy	+20,300	New	+$82.6K	﹤0.01%	10565
2019 Q1	–	Sell	-10,900	Closed	-$119K	–	10238
2018 Q4	$119K	Buy	+10,900	New	+$137K	﹤0.01%	8125
2018 Q2	–	Sell	-15,300	Closed	-$132K	–	10736
2018 Q1	$132K	Buy	15,300 +4,500	+42%	+$39.5K	﹤0.01%	8592
2017 Q4	$102K	Buy	10,800 +300	+3%	+$2.34K	﹤0.01%	8682
2017 Q3	$82K	Buy	+10,500	New	+$78.8K	﹤0.01%	8426

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

Jeff Yass's KIN Position: Q3 2021 in Review

Jeff Yass sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 54,003 shares — an estimated $495K sold.

Jeff Yass first reported a position in KIN in Q2 2015 and held it in 16 quarters. The position peaked at $612K in Q2 2015. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Jeff Yass reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Jeff Yass sold 54,003 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $495K.
Jeff Yass first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 16 quarters.
Jeff Yass's Kindred Biosciences, Inc. position peaked at $612K in Q2 2015.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.